News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Elekta AB Initiates Repurchase of Own Shares
July 5, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Elekta has on July 4, 2007, repurchased 154,200 B shares at an average price of SEK 117.37. Elekta’s current holding of own shares (treasury stock) amounts to 913,471 B shares. The total number of shares in Elekta as of 31 May, 2007 is 93,794,776.
Twitter
LinkedIn
Facebook
Email
Print
Europe
MORE ON THIS TOPIC
Job Trends
Takeda cuts send layoffs soaring in May, rising year over year
May 19, 2026
·
4 min read
·
Angela Gabriel
Mergers & acquisitions
Mid-sized European drugmakers are snapping up US biotechs. Will the surge continue?
May 13, 2026
·
4 min read
·
Nick Paul Taylor
Huntington’s disease
UniQure eyes UK approval for embattled Huntington’s gene therapy after FDA quarrel
April 30, 2026
·
2 min read
·
Heather McKenzie
Company closure
6 biotechs that called it quits in Q1
April 30, 2026
·
6 min read
·
Angela Gabriel